These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 18726789)

  • 1. Review of the toxicology of chlorpyrifos with an emphasis on human exposure and neurodevelopment.
    Eaton DL; Daroff RB; Autrup H; Bridges J; Buffler P; Costa LG; Coyle J; McKhann G; Mobley WC; Nadel L; Neubert D; Schulte-Hermann R; Spencer PS
    Crit Rev Toxicol; 2008; 38 Suppl 2():1-125. PubMed ID: 18726789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinesterase inhibition in chlorpyrifos workers: Characterization of biomarkers of exposure and response in relation to urinary TCPy.
    Garabrant DH; Aylward LL; Berent S; Chen Q; Timchalk C; Burns CJ; Hays SM; Albers JW
    J Expo Sci Environ Epidemiol; 2009 Nov; 19(7):634-42. PubMed ID: 18716607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of prenatal and childhood chlorpyrifos exposure with Neurodevelopment of 3-year-old children.
    Guo J; Zhang J; Wu C; Lv S; Lu D; Qi X; Jiang S; Feng C; Yu H; Liang W; Chang X; Zhang Y; Xu H; Cao Y; Wang G; Zhou Z
    Environ Pollut; 2019 Aug; 251():538-546. PubMed ID: 31108286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appraisal of risks from nonoccupational exposure to chlorpyrifos.
    Cochran RC
    Regul Toxicol Pharmacol; 2002 Feb; 35(1):105-21. PubMed ID: 11846640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of repeated nicotine and alcohol coexposure on in vitro and in vivo chlorpyrifos dosimetry and cholinesterase inhibition.
    Lee S; Poet TS; Smith JN; Hjerpe AL; Gunawan R; Timchalk C
    J Toxicol Environ Health A; 2011; 74(20):1334-50. PubMed ID: 21899407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothesis-based weight-of-evidence evaluation of the neurodevelopmental effects of chlorpyrifos.
    Prueitt RL; Goodman JE; Bailey LA; Rhomberg LR
    Crit Rev Toxicol; 2011 Nov; 41(10):822-903. PubMed ID: 22085162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the reference dose for chlorpyrifos: proceedings of an expert panel.
    Clegg DJ; van Gemert M
    J Toxicol Environ Health B Crit Rev; 1999; 2(3):211-55. PubMed ID: 10429680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorpyrifos exposure in farmers and urban adults: Metabolic characteristic, exposure estimation, and potential effect of oxidative damage.
    Wang L; Liu Z; Zhang J; Wu Y; Sun H
    Environ Res; 2016 Aug; 149():164-170. PubMed ID: 27208467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-dependent pharmacokinetic and pharmacodynamic response in preweanling rats following oral exposure to the organophosphorus insecticide chlorpyrifos.
    Timchalk C; Poet TS; Kousba AA
    Toxicology; 2006 Mar; 220(1):13-25. PubMed ID: 16343727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cholinesterase enzymes following a single dermal dose of chlorpyrifos and methyl parathion, alone and in combination, in pregnant rats.
    Abu-Qare AW; Abdel-Rahman A; Brownie C; Kishk AM; Abou-Donia MB
    J Toxicol Environ Health A; 2001 Jun; 63(3):173-89. PubMed ID: 11405414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinesterase inhibition and toxicokinetics in immature and adult rats after acute or repeated exposures to chlorpyrifos or chlorpyrifos-oxon.
    Marty MS; Andrus AK; Bell MP; Passage JK; Perala AW; Brzak KA; Bartels MJ; Beck MJ; Juberg DR
    Regul Toxicol Pharmacol; 2012 Jul; 63(2):209-24. PubMed ID: 22504667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gestational exposure to chlorpyrifos: comparative distribution of trichloropyridinol in the fetus and dam.
    Hunter DL; Lassiter TL; Padilla S
    Toxicol Appl Pharmacol; 1999 Jul; 158(1):16-23. PubMed ID: 10387928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a source-to-outcome model for dietary exposures to insecticide residues: an example using chlorpyrifos.
    Hinderliter PM; Price PS; Bartels MJ; Timchalk C; Poet TS
    Regul Toxicol Pharmacol; 2011 Oct; 61(1):82-92. PubMed ID: 21722690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotoxic effect of dermally-applied chlorpyrifos and cypermethrin in Wistar rats.
    Latuszyńska J; Luty S; Raszewski G; Tokarska-Rodak M; Przebirowska D; Przylepa E; Haratym-Maj A
    Ann Agric Environ Med; 2001; 8(2):163-70. PubMed ID: 11748873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An age-dependent physiologically based pharmacokinetic/pharmacodynamic model for the organophosphorus insecticide chlorpyrifos in the preweanling rat.
    Timchalk C; Kousba AA; Poet TS
    Toxicol Sci; 2007 Aug; 98(2):348-65. PubMed ID: 17504771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course of inhibition of cholinesterase and aliesterase activities, and nonprotein sulfhydryl levels following exposure to organophosphorus insecticides in mosquitofish (Gambusia affinis).
    Boone JS; Chambers JE
    Fundam Appl Toxicol; 1996 Feb; 29(2):202-7. PubMed ID: 8742317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral and dermal absorption of chlorpyrifos: a human volunteer study.
    Griffin P; Mason H; Heywood K; Cocker J
    Occup Environ Med; 1999 Jan; 56(1):10-3. PubMed ID: 10341740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A human life-stage physiologically based pharmacokinetic and pharmacodynamic model for chlorpyrifos: development and validation.
    Smith JN; Hinderliter PM; Timchalk C; Bartels MJ; Poet TS
    Regul Toxicol Pharmacol; 2014 Aug; 69(3):580-97. PubMed ID: 24200834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of chlorpyrifos and 3,5,6-trichloro-2-pyridinol in rat saliva after chlorpyrifos administration.
    Smith JN; Wang J; Lin Y; Klohe EM; Timchalk C
    Toxicol Sci; 2012 Dec; 130(2):245-56. PubMed ID: 22874420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dialkyl phosphates as biomarkers of organophosphates: the current divide between epidemiology and clinical toxicology.
    Sudakin DL; Stone DL
    Clin Toxicol (Phila); 2011 Nov; 49(9):771-81. PubMed ID: 22077242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.